Diana Stefani-Hunyady

Company: Incyte

Job title: Senior Medical Director, Global Clinical Development, Inflammation & Autoimmunity

Seminars:

Panel Discussion: Can Topical and Systemic Therapies Each Find Their Place in the Future of Dermatology Drug Development? 3:30 pm

How should we balance the clinical and commercial drivers behind topical and systemic innovation, especially as realworld prescribing habits continue to favor topicals? How are these approaches viewed from the patient, regulator and investor perspective? Which factors, including disease severity, body surface area, and treatment setting, best guide whether a topical, systemic, or combination approach…Read more

day: Day One PM

Panel Discussion: Closing the Gap Between Innovation and Impact: Patient & Advocacy Perspectives in Modern Dermatology Drug Development 3:30 pm

What makes a trial truly worth participating in from a patient’s and dermatologist’s perspective? What are the key considerations – pros and cons? How can developers better reflect patient-perceived benefit, to ensure quality of life and daily function are both addressed as a holistic measure of disease improvement? Highlighting the importance of early and meaningful…Read more

day: Day Two PM

Advancing Precision Depigmentation Through Real-World Learnings in Vitiligo 9:15 am

Key outcomes and safety insights from adult and adolescent trials investigating topical JAK inhibition in vitiligo Translating clinical success to pediatric populations and adapting protocols for less extensive disease Navigating operational and regulatory challenges including enrollment barriers and long-term data expectations Applying lessons from atopic dermatitis programs to improve trial design, endpoint strategy, and FDA…Read more

day: Day One AM

Roundtable Discussion: Pathways to Reimbursement Success in Immuno-Dermatology: Insights from the Reimbursor Perspective 9:30 am

Explore key metrics and data requirements reimbursement bodies prioritize to ensure therapies are deemed clinically and economically viable Learn how data informs reimbursement decisions and substantiates long-term value propositions for immuno-dermatology therapies Gain insights into harmonizing trial design and endpoints with HTA criteria to address unmet needsRead more

day: Day Two AM